期刊
JOURNAL OF INVESTIGATIVE DERMATOLOGY
卷 135, 期 9, 页码 2292-2300出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/jid.2015.139
关键词
-
类别
资金
- Wilhelm-Sander Stiftung [2011-066.1]
- Berliner Krebsgesellschaft
- Verein der Freunde der Dermatologischen Klinik Krefeld e.V.
Cutaneous T-cell lymphomas (CTCLs) form a heterogeneous group of non-Hodgkin's lymphomas characterized by only poor prognosis in advanced stage. Despite significant progress made in the identification of novel genes and pathways involved in the pathogenesis of cutaneous lymphoma, the therapeutic value of these findings has still to be proven. Here, we demonstrate by gene expression arrays that Aurora kinase A is one of the highly overexpressed genes of the serine/threonine kinase in CTCL. The finding was confirmed by quantitative reverse transcriptase-PCR, western blotting, and immunohistochemistry in CTCL cell lines and primary patient samples. Moreover, treatment with a specific Aurora kinase A inhibitor blocks cell proliferation by inducing cell cycle arrest in G2 phase, as well as apoptosis in CTCL cell lines. These data provide a promising rationale for using Aurora kinase A inhibition as a therapeutic modality of CTCL.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据